Dr Reddys Q4 Net Profit down to Rs 162.26 Crores

Dr Reddys Laboratories Ltd (NYSE:RDY) has announced the results for the quarter & year ended March 31, 2008.

The Unaudited results for the Quarter ended March 31, 2008: The Company has posted a net profit of Rs 1622.60 million for the quarter ended March 31, 2008 as compared to Rs 2689.00 million for the quarter ended March 31, 2007. Total Income has decreased from Rs 11510.60 million for the quarter ended March 31, 2007 to Rs 10384.70 million for the quarter ended March 31, 2008.

The Audited results for the Year ended March 31, 2008: The Company has posted a net profit of Rs 4752.20 million for the year ended March 31, 2008 as compared to Rs 11768.60 million for the year ended March 31, 2007. Total Income has decreased from Rs 40843.10 million for the year ended March 31, 2007 to Rs 35850.10 million for the year ended March 31, 2008.

The Audited consolidated results for the Year ended March 31, 2008: The Group has posted a net profit attributable to the shareholders of the parent of Rs 4381.30 million for the year ended March 31, 2008 as compared to Rs 9658.90 million for the year ended March 31, 2007. Total Income has decreased from Rs 66417.60 million for the year ended March 31, 2007 to Rs 51954.50 million for the year ended March 31, 2008.

The Unaudited Consolidated results as per US GAAP are as follows: The Group has posted a net profit of Rs 4678.042 million (USD 116.893 million) for the year ended March 31, 2008 as compared to Rs 9326.838 million for the year ended March 31, 2007. Revenues has decreased from Rs 65095.092 million for the year ended March 31, 2007 to Rs 50005.626 million (USD 1249.516 million) for the year ended March 31, 2008.

The figures for year ended March 31, 2007 consolidated results as per US GAAP are Audited.

Source : Equity Bulls

Keywords